New Jersey's S 2260 strengthens legal protections for patients and providers accessing or delivering reproductive and gender-affirming health care services within the state. The bill explicitly defines "legally protected health care activities" to include seeking, providing, or assisting with these services (such as abortion, contraception, or gender-affirming care), regardless of a patient's location. It prohibits obstruction, intimidation, or physical barriers at facilities offering these services and grants licensing boards authority to impose civil penalties for violations. This directly affects patients traveling to New Jersey for care (not available in their home states) and healthcare providers operating in these fields. The law codifies existing protections to prevent harassment or violence against these services, following increased threats and protests nationwide after the overturning of Roe v. Wade.
S 3412 would require certain social media platforms in New Jersey to display a black box warning about mental health risks to users, similar to health warnings on tobacco products. The bill targets platforms primarily designed for social connection (like Facebook or TikTok) that have users in New Jersey, excluding services focused on news, entertainment, or e-commerce. This requirement is based on findings that youth social media use exceeding three hours daily doubles risks of depression and anxiety, and platforms are aware of these harms. The warning must be displayed on platforms meeting the bill's definition of "covered social media platforms," affecting all users of those services in the state.
This bill establishes a Social Media Research Center at a New Jersey four-year public university selected by the Higher Education Secretary. The center will conduct research on social media's effects on youth mental health, develop online safety resources for public schools, and provide recommendations to state agencies. It will also administer grants for social media research using a peer-reviewed process modeled after the NIH, and require annual reports on its work. The bill directly affects New Jersey public universities (as hosts), public schools (through educational resources), and state agencies (by requiring data sharing).
This bill authorizes New Jersey's Department of Health (DOH) to seek participation in the World Health Organization's Global Outbreak Alert and Response Network (GOARN), a global network for disease outbreak coordination. It directly affects the DOH and New Jersey's public health response system by enabling collaboration on outbreak detection, information-sharing, and emergency preparedness. Key provisions allow the DOH to communicate with GOARN, submit applications, designate contact points, and participate in trainings without creating new legal obligations or requiring additional funding beyond existing appropriations. The bill specifically clarifies it does not establish New Jersey's membership in the WHO or override federal law.
This bill permanently extends pay parity for telemedicine and telehealth services in New Jersey, requiring health insurance carriers to reimburse providers at the same rates as in-person care. It directly affects insurance companies, healthcare providers, and patients by mandating that out-of-pocket costs like deductibles and copayments for virtual visits cannot exceed those for in-person appointments. The legislation also prohibits insurers from restricting telehealth platforms, limiting service locations, or denying coverage for routine remote monitoring if the same care would be covered in person. Additionally, carriers must continue to allow patients to choose between in-person and virtual care rather than forcing telehealth as a substitute.
This bill codifies protections for patients and providers accessing or offering legally permitted reproductive and gender-affirming health care in New Jersey. It prohibits obstructing or intimidating individuals at facilities providing these services - including blocking entrances, causing reasonable fear of harm, or threatening violence. The law defines "legally protected health care activity" to cover all such services lawful in New Jersey, regardless of a patient’s location, and applies to both in-state residents and out-of-state patients seeking care here. It expands existing safeguards by explicitly banning physical obstructions and threats at facilities offering these services.
This bill permanently requires New Jersey health insurance carriers to pay the same reimbursement rate for telemedicine and telehealth services as they do for in-person visits, provided the service is otherwise covered. It ensures patients face no higher deductibles, copays, or coinsurance for telehealth compared to in-person care. The law prohibits insurers from restricting where telehealth services can occur, limiting which technology platforms providers can use, or denying coverage for routine remote monitoring. It directly affects health insurance companies, healthcare providers offering telehealth, and patients receiving covered telehealth services. The policy change applies to all health benefits plans in New Jersey without time limits.
This bill requires social media platforms with significant user activity in New Jersey to display prominent warning labels about mental health risks during account sign-up and when users access certain features. It specifically targets platforms that allow social interaction (like profile creation and content sharing) and directly affects minors under 18, as defined by the bill. The warnings must highlight risks identified by the U.S. Surgeon General, including links between heavy social media use and increased depression, anxiety, and sleep disruption in youth. Platforms must comply with these labeling requirements to inform users and families about potential harms. The bill does not impose additional restrictions beyond the warning labels.
This bill would require New Jersey Medicaid to cover ovulation-enhancing drugs and related medical services without restrictions for beneficiaries experiencing infertility. It directly affects low-income New Jersey residents enrolled in Medicaid who seek infertility treatment. The key provision amends Medicaid law to explicitly include these services as a standard benefit, removing prior authorization requirements. This change would expand current coverage to ensure these treatments are accessible as routine care for eligible individuals.
This bill regulates pharmacy benefits managers (PBMs) and insurance carriers to increase transparency and fairness in prescription drug coverage. It requires carriers and PBMs to establish pharmacy and therapeutics committees with strict conflict-of-interest rules, prohibits commission-based PBM compensation (mandating flat fees instead), and mandates detailed reporting of PBM fees for insurance filings. The law directly affects insurers, PBMs, and pharmacies by changing how drug formularies (approved drug lists) are managed and how PBM costs are calculated and disclosed. Key provisions include banning preferential formulary placement for higher-cost drugs over lower-cost generics/biosimilars and requiring actuarial documentation for PBM compensation. The bill aims to reduce patient cost-sharing and ensure PBM compensation aligns with administrative costs.
